Compounds > 1-methyl-4-phenylpyridinium
Page last updated: 2024-08-23

1-methyl-4-phenylpyridinium and Dyskinesia Syndromes

1-methyl-4-phenylpyridinium has been researched along with Dyskinesia Syndromes in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19903 (60.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Aiyaz, M; Gayathri, N; Harsha, PK; Jamshidi, N; Padmanabhan, B; Ranganayaki, S; Rashmi, SK; Srinivas Bharath, MM1
Aoyama, K; Matsumura, N; Nakaki, T; Watabe, M1
Bradbury, AJ; Costall, B; Domeney, AM; Jenner, PG; Marsden, CD; Naylor, RJ; Testa, B1
Bradbury, AJ; Costall, B; Domeney, AM; Jenner, PJ; Marsden, CD; Naylor, RJ1
Mihatsch, W; Przuntek, H; Russ, H1

Other Studies

5 other study(ies) available for 1-methyl-4-phenylpyridinium and Dyskinesia Syndromes

ArticleYear
Inhibition of mitochondrial complex II in neuronal cells triggers unique pathways culminating in autophagy with implications for neurodegeneration.
    Scientific reports, 2021, 01-15, Volume: 11, Issue:1

    Topics: 1-Methyl-4-phenylpyridinium; Animals; Autophagy; Cell Death; Cell Line; Cell Survival; Cells, Cultured; Electron Transport Complex I; Electron Transport Complex II; Gene Expression; Gene Expression Profiling; Mitochondria; Movement Disorders; Neurodegenerative Diseases; Neurons; Neuroprotection; Neurotoxins; Nitro Compounds; Propionates; Rats; Transcriptome

2021
Oxidative stress on EAAC1 is involved in MPTP-induced glutathione depletion and motor dysfunction.
    The European journal of neuroscience, 2008, Volume: 27, Issue:1

    Topics: 1-Methyl-4-phenylpyridinium; Acetylcysteine; Animals; Aspartic Acid; Behavior, Animal; Cysteine; Disease Models, Animal; Drug Interactions; Excitatory Amino Acid Transporter 1; Free Radical Scavengers; Glutathione; Humans; Hydrogen Peroxide; Hydroxamic Acids; In Vitro Techniques; Indazoles; Male; Mice; Mice, Inbred C57BL; Movement Disorders; MPTP Poisoning; Neuroprotective Agents; Oxidative Stress; Substantia Nigra

2008
The toxic actions of MPTP and its metabolite MPP+ are not mimicked by analogues of MPTP lacking an N-methyl moiety.
    Neuroscience letters, 1985, Oct-24, Volume: 61, Issue:1-2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Diseases; Chemical Phenomena; Chemistry; Corpus Striatum; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Movement Disorders; Norepinephrine; Pyridines; Pyridinium Compounds; Rats; Serotonin; Substantia Nigra

1985
The neurotoxic actions of 6-hydroxydopamine infused into the rat substantia nigra.
    Neuroscience letters, 1986, Jun-18, Volume: 67, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Homovanillic Acid; Hydroxydopamines; Hydroxyindoleacetic Acid; Male; Movement Disorders; Neurotransmitter Agents; Oxidopamine; Pyridines; Pyridinium Compounds; Rats; Rats, Inbred Strains; Substantia Nigra

1986
Intracerebroventricular administration of 1-methyl-4-phenylpyridinium ion in mice: effects of simultaneously administered nomifensine, deprenyl, and 1-t-butyl-4,4-diphenylpiperidine.
    Journal of neural transmission, 1988, Volume: 71, Issue:3

    Topics: 1-Methyl-4-phenylpyridinium; Animals; Brain; Catecholamines; Caudate Nucleus; Dose-Response Relationship, Drug; Drug Interactions; Female; Injections, Intraventricular; Male; Monoamine Oxidase Inhibitors; Movement Disorders; Nomifensine; Phenethylamines; Piperidines; Pyridinium Compounds; Selegiline; Serotonin

1988